Traders should monitor AEON for potential delisting risk ahead of the August 3, 2026 deadline; any failure to show equity improvement or financing activity increases the likelihood of a forced OTC move, which typically triggers further price declines. The current market cap of $22M may not reflect imminent exchange risk.
Price Chart
Executive Summary
AEON Biopharma received a notice from NYSE American that it is now non-compliant with an additional listing standard due to a stockholders' deficit of approximately $55 million as of December 31, 2025, and losses in three of its four most recent fiscal years. This follows a prior notice in February 2025 and does not immediately impact its listing, but the company must regain compliance by August 3, 2026, or face potential delisting. The situation reflects deteriorating financial health and heightened risk of exchange removal.
Key Facts
- AEON is now non-compliant with NYSE American's Section 1003(a)(ii), requiring $4.0 million in stockholders' equity due to losses in three of four recent fiscal years.
- Stockholders' deficit was approximately $55 million as of December 31, 2025.
- The company previously received a non-compliance notice in February 2025 under Section 1003(a)(i) and was given until August 3, 2026, to regain compliance.
- Common stock continues to trade under 'AEON' with a '.BC' indicator denoting non-compliance.
- Failure to regain compliance by August 3, 2026, or lack of progress during the plan period, could trigger delisting proceedings.
Financial Impact
Stockholders' deficit of $55 million as of year-end 2025; no revenue or earnings growth indicated
Risk Factors
- Risk of delisting if compliance is not achieved by August 3, 2026
- Inability to raise capital to restore stockholders' equity
- Continued operating losses exacerbating financial condition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3268136 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | DEF 14A | $0.2350 | awaiting T+5 | — | $0.2497 (+6.26%) |
Oct 23, 2026 3d ago | 8-K | $0.2399 | awaiting T+5 | — | $0.2497 (+4.09%) |
Sep 30, 2026 27d ago | 8-K | $0.3000 $0.3110 | ▲ +3.67% | ▲ +1.75% | $0.2497 (−16.77%) |
Aug 21, 2026 9w ago | 3 | $0.1974 $0.2959 | ▲ +49.90% | ▲ +49.43% | $0.2497 (+26.49%) |
Aug 19, 2026 9w ago | Press Release | $0.1980 $0.2515 | ▲ +27.02% | ▲ +27.41% | $0.2497 (+26.11%) |
Aug 12, 2026 10w ago | Press Release | $0.2706 $0.1931 | ▼ −28.64% | ▼ −26.68% | $0.2497 (−7.72%) |
Jul 23, 2026 13w ago | 8-K | $0.2507 $0.2552 | ▼ −1.79% | ▼ −1.42% | $0.2497 (+0.40%) |
Jul 15, 2026 14w ago | 8-K | $0.2974 $0.2600 | ▲ +12.58% | ▲ +10.91% | $0.2497 (+16.04%) |
Jul 15, 2026 14w ago | 424B4 | $0.2997 $0.2752 | ▲ +8.17% | ▲ +7.19% | $0.2497 (+16.68%) |
Jul 14, 2026 15w ago | EFFECT | $0.3570 $0.2890 | ▲ +19.05% | ▲ +17.75% | $0.2497 (+30.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers